Doctor profile · Federal record
Dr. MATTHEW BURDEN, M.D.
Hospitalist Physician (CMS: INTERNAL MEDICINE) · Internal Medicine Physician · BIRMINGHAM, AL
- NPI 1245694363
- Accepts Medicare
- 10 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
619 19TH ST S
BIRMINGHAM, AL 352490012
(205) 934-4011 - Mailing address
-
PO BOX 55310
BIRMINGHAM, AL 352555310
Credentials & registration
- NPI registered
- April 2016 — 10 yrs on file
- Profile last updated
- June 29, 2023
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 208M00000X — NUCC code
- State license (1)
- Alabama #36484
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1245694363. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
730
Distinct HCPCS
4
Medicare allowed
$68,345
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 359 | 151 | $73 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 216 | 125 | $111 | |
99239 |
Hospital discharge day management, more than 30 minutes | 124 | 124 | $106 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 31 | 30 | $158 |
In context: peer comparison
Among 44 peers in this city , average services per provider: 107. This provider delivers 6.8× the peer median.Open Payments
Industry payments received
All-time total
$1,223
Transactions
70
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 12 | $164.88 | |
| AstraZeneca Pharmaceuticals LP | 8 | $156.75 | |
| ABBVIE INC. | 12 | $136.35 | |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $125.01 | |
| Otsuka America Pharmaceutical, Inc. | 5 | $89.16 | |
| Lilly USA, LLC | 4 | $66.27 | |
| Janssen Pharmaceuticals, Inc | 4 | $65.20 | |
| Novartis Pharmaceuticals Corporation | 4 | $62.36 | |
| Corcept Therapeutics | 3 | $60.97 | |
| Astellas Pharma US Inc | 3 | $56.06 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39.27 | |
| Mylan Specialty L.P. | 2 | $35.85 | |
| GlaxoSmithKline, LLC. | 2 | $33.84 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33.48 | |
| SHIELD THERAPEUTICS INC | 2 | $33.48 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
277
Patients
189
Total drug cost
$27,288
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 32 | 22 | $213 |
| Eliquis (Apixaban) | Brand | 30 | 18 | $18,706 |
| Amlodipine Besylate | Generic | 26 | 18 | $66 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 21 | 20 | $98 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 20 | 11 | $147 |
| Carvedilol | Generic | 19 | 13 | $157 |
| Cefdinir | Generic | 18 | 18 | $123 |
| Furosemide | Generic | 17 | 14 | $80 |
| Pantoprazole Sodium | Generic | 17 | 16 | $122 |
| Prednisone | Generic | 16 | 16 | $44 |